Swiss Semiconductors Stock News

Avolta closed at CHF48.34 after the H1 2026 release, roughly flat over the past week and still down about 11% over the past month. The stock is trading on a rich P/E of 31.9x, yet the latest half shows the earnings story that has kept investors engaged. Net income reached CHF35.0m with basic earnings per share of CHF0.25, and management kept the focus on cash with equity free cash flow of €207m and leverage around 2.07x. The key issue for investors is whether that earnings and cash mix...

Bachem Holding walked into this earnings season with a growth-stock label and a rich P/E of 37.6x, yet the share price has drifted down about 3% over the past month to CHF 74.80. Today's H1 numbers put the spotlight on something less glamorous and more important for you as an investor. The peptide and oligonucleotide specialist is pouring money into capacity, with H1 capital expenditure of CHF 148m and EBITDA margin sitting at 25.4%. The key question is whether this heavy build-out and margin...

INFICON Holding stock closed at CHF162.60 on 31 July, roughly flat over the past week after a choppy few months. The market reaction looks cautious. The earnings story is not. H1 2026 showed clear profit recovery in a capital intensive semiconductor equipment world, with basic earnings per share at US$2.27 and trailing net profit margin at 13.5%. The immediate price move tells you how traders felt today. The multi year forecasts and the valuation you are paying for that recovery are what...

Why Kardex Holding Stock Is Back In Focus After Its Half Year 2026 Results Kardex Holding (SWX:KARN) is back on investor radars after its half year 2026 update, which combined strong growth in bookings and order backlog with a 40% EBIT decline and a profit warning. The company reported half year sales of €440.5 million compared with €415.7 million a year earlier, while net income moved from €36.2 million to €22.6 million and basic EPS from €4.69 to €2.93. See our latest analysis for Kardex...

Idorsia closed at CHF6.12, roughly flat over the past week but still carrying a strong 90 day rebound in the share price. The market has been treating this as a recovery story. The Q2 earnings headline pulls investors back to the balance sheet. The company is still loss making and carries negative shareholders’ equity, and yet trades on a price to sales ratio of 7.8x, below both the European biotech average and key peers. The central question now is whether the liquidity moves and earnings...

Zehnder Group stock closed at CHF67.70 on Friday after a steady run over the past month. Yet the real story sits in the income statement rather than the ticker. The latest half year numbers put a bright spotlight on profitability. Net profit margin now stands at 6% compared with 2.4% a year earlier and earnings over the past 12 months are sharply higher. That kind of margin rebuild matters more than a single day’s move. For long term investors in building ventilation and climate systems, the...

Bucher Industries stock closed at CHF316 after a choppy week that left shares down about 4.5% over seven days, even as the latest half year numbers landed. The market focused on softer profit metrics more than the headline revenue figure of CHF1,471.4m for H1 2026. Net income of CHF87.5m and basic earnings per share of CHF8.90 point to a profit squeeze that matters far more than a single day price move. For long term holders, the key question now is how this margin pressure fits with the...

Sika AG ( VTX:SIKA ) investors will be delighted, with the company turning in some strong numbers with its latest...

It's been a good week for Sulzer AG ( VTX:SUN ) shareholders, because the company has just released its latest...

Investors in SIG Group AG ( VTX:SIGN ) had a good week, as its shares rose 9.5% to close at CHF15.15 following the...

Investors signalled that they were pleased with Roche Holding AG's ( VTX:ROP ) most recent earnings report. According...

While Zehnder Group AG ( VTX:ZEHN ) might not have the largest market cap around , it saw a decent share price growth...

Shareholders might have noticed that Logitech International S.A. ( VTX:LOGN ) filed its quarterly result this time last...

UBS Group stock went into this earnings print with momentum, up about 24% over the past three months and trading at roughly 17x P/E, a premium to the wider European capital markets sector but below the Swiss market. Today the real story is not the headline share price move. It is whether investors trust a banking giant that is now posting quarterly net income of about US$2.8b while still carrying the memory of a US$5.0b one off hit in the recent past. The core tension for investors is simple...

Naturenergie Holding AG recently reported past half-year results to June 30, 2026, with sales of €661.6 million versus €810.2 million a year earlier and net income of €45.5 million versus €69.7 million. The figures highlight how weaker top-line performance has filtered through to profits, raising questions about cost efficiency and business mix over the period. Next, we’ll examine how this contraction in sales and earnings shapes Naturenergie Holding’s investment narrative and future...

Ascom Holding came into this earnings day with a stock that had drifted, down around 11% over the past month and slightly weaker over the past week, while trading on a single digit P/E multiple. The H1 2026 numbers did not bring a flashy revenue surge, but they did show what matters most here. Profitability is quietly tightening, with basic earnings per share at CHF0.16 for the half and trailing net profit margin at 6.3%. The key point is that profit quality is improving while the market...

Autoneum Holding stock closed at CHF130.40 on 30 July, capping a strong run over the past month. Yet the real story in these H1 2026 results is not the share price. It is how a relatively low P/E of 12.3x sits beside a double digit trailing twelve month earnings per share of CHF10.60. For short term traders, the move has already happened. For longer term holders, the key question now is how to weigh that earnings power and modest 2.7% net profit margin against high debt and an uneven dividend...

Swissquote Group Holding (SWX:SQN) drew fresh attention after Goldman Sachs upgraded the stock to buy from neutral, citing stronger earnings potential in securities trading, foreign exchange and net interest income. See our latest analysis for Swissquote Group Holding. That upgrade comes after a sharp short term rebound in Swissquote Group Holding, with a 1 month share price return of 16.21% and a 3 year total shareholder return of 139.29%, although the 1 year total shareholder return is...

Sika (SWX:SIKA) drew fresh attention after its half year 2026 results, which showed broadly steady sales and earnings in Swiss francs, along with an upgrade to full year local currency sales guidance. See our latest analysis for Sika. The recent half year 2026 update seems to have shifted sentiment around Sika, with the stock showing a 7 day share price return of 13.86% and a 90 day share price return of 24.88%. However, the 1 year total shareholder return is down 6.31% and the 5 year total...

The European stock market has recently shown resilience, with the pan-European STOXX Europe 600 Index posting a modest gain amid robust corporate earnings and geopolitical tensions. As investors navigate these complex conditions, identifying undervalued stocks can offer potential opportunities for those seeking to capitalize on price discrepancies relative to fair value.

As European markets navigate a landscape marked by robust corporate earnings and geopolitical tensions, the pan-European STOXX Europe 600 Index recently posted gains, reflecting investor optimism amid higher oil prices and potential policy shifts. In this environment, growth companies with substantial insider ownership can be particularly appealing as they often signal confidence from those closest to the business, aligning well with market conditions that value stability and strategic...

Soft earnings didn't appear to concern V-ZUG Holding AG's ( VTX:VZUG ) shareholders over the last week. We did some...

Roche Holding (SWX:ROP) received FDA 510(k) clearance for its cobas BV/CV molecular diagnostic assay, expanding its sexual health testing portfolio in the United States. The assay is designed to support more accurate diagnosis of bacterial vaginosis and vulvovaginal candidiasis, two common women's health conditions that are often misdiagnosed. The EMA’s Committee for Medicinal Products for Human Use issued a positive opinion for Susvimo, a ranibizumab implant for neovascular age related...

Schindler Holding (SWX:SCHN) reaffirmed its 2026 earnings guidance and released half-year results, giving investors fresh detail on how Modernization, Service and New Installations are shaping the company’s revenue profile this year. See our latest analysis for Schindler Holding. The reaffirmed guidance and higher earnings come against a mixed share price picture for Schindler Holding, with the stock down 12.11% on a year-to-date share price return and the 1-year total shareholder return also...